The ketogenic diet; clinical update
|
|
- Grant Logan
- 6 years ago
- Views:
Transcription
1 The ketogenic diet; clinical update J Helen Cross UCL-Institute of Child Health, Great Ormond Street Hospital for Children NHS Trust, London, & NCYPE, Lingfield, UK
2 The ketogenic diet what is it? A high fat diet, designed to mimic the metabolic effects of starvation 1910 Conklin patient deprived of food up to 25 days Cure rate for epilepsy 50-90% 1921 Wilder..benefits of fasting could be obtained if ketonemia was produced by other means 1924 Peterman Calculation and effectiveness of the proposed ketogenic diet 17 patients, 10 seizure free, 4 marked improvement 1971 Huttenlocher Medium chain triglyceride oil more ketogenic per calorie, permitted greater bulk of other foods, MCT diet
3 Does it work? Author Year No >90% >50% <50% Wilkins % 21% 50% Livingston % 34% 22% Kinsman et al Huttenlocher et al % 38% 33% % 50% Sills et al % 20% 56%
4 Types of Ketogenic Diet Classical diet MCT diet Modified MCT diet 4:1/3:1 fat to CHO Use of MCT oil Low CHO
5 Indications Metabolic defects where unable to effectively metabolise glucose GLUT 1 deficiency Drug resistant epilepsy if not a candidate for epilepsy surgery? Poor tolerance to AEDs Not a natural diet
6 Evidence base for efficacy? Lefevre and Aronson 2000 Systematic review of studies Uncontrolled studies 9/11 from single institution Freeman et al 1998 N=150 LCT (27<2yrs) Consecutive children, follow up > 12m 3m (N=125) 31%>90%reduction 12m (N=83) 20%>90%reduction Kang et al 2005 N=199 LCT (49<2yrs) Retrospective study, 12m review 3m (N=175) 35% seizure free (62%>50% reduction) 12m (N=91) 25% seizure free (41%>50% reduction)
7 Evidence base for efficacy? Henderson et al J Child Neurol 2006;21: A meta-analysis 392 abstracts ; 19 met inclusion criteria Collective population 1084, mean age /-3.43 Pooled odds ratio using random effect model of treatment success amongst patients staying on diet relative to discontinuation 2.25 ( ) Future study requires definition of seizure types, long term review patient drop out analysis
8 Evidence base for efficacy? D Keene Ped Neurol 2006;35:1-5 A systematic review 26 studies;14 met criteria for inclusion Outcome measures degree of seizure control, duration patient remained on diet, occurrence of adverse events Total collective population N=972 At 6m 15.6% (CI ) seizure free 33.0% (CI ) >50% reduction
9 Evidence base for drug use Class 1 Randomised controlled trial a: Meta-analysis b: Single study Class II At least one controlled study without randomisation or at least one other quasi experimental study Class III Non experimental descriptive study Class IV Case reports
10 Randomised Controlled Trials Randomisation limits the potential for selection bias Blinding minimises information and investigator bias Precision determined by sufficient sample size, accurate assessment of outcome endpoints
11 SMEI Neonatal Absence UCL - Institute of Child Health RCTs in childhood epilepsy No of RCTs Partial epilepsy GTC LGS Infantile spasms JME
12 The ketogenic diet Why should we require a different standard of a further antiepileptic treatment?
13 A randomised controlled trial of the efficacy and tolerability of two ketogenic diets EG Neal, HM Chaffe, R Schwartz, M Lawson, N Edwards, G Fitzsimmons, A Whitney, JH Cross Inclusion criteria Age 2-16 years Minimum 7 seizures/week > 2 AEDs previously Exclusion criteria Family history of hyperlipidaemia Organic aciduria Previous trial of ketogenic diet
14 Randomised controlled trial Randomise MCT Subject entry Classical Screening visit Diet 12m 4 weeks Controls 12 weeks Neal et al 2007
15 Demographics Diet group Control group Boys Girls Allocated to study group (n=73) 38 (52.1%) 35 (47.9%) Included in final analysis (n=54) 30 (55.6%) 24 (44.4%) Allocated to study group (n=72) 38 (52.8%) 34 (47.2%) Included in final analysis (n=49) 25 (51.0%) 24 (49.0%) Aged 2-6 yrs Aged 7-11 yrs Aged yrs 37 (50.7%) 27 (37.0%) 9 (12.3%) 28 (51.9%) 20 (37.0%) 6 (11.1%) 29 (40.3%) 32 (44.4%) 11 (15.3%) 20 (40.8%) 20 (40.8%) 9 (18.4%) Focal epilepsy Generalised epilepsy Mean daily seizures At recruitment : no medication 6, one medication 20, two medications 53, three medications 54, four medications 11, five medications one
16 Randomised (n=145) Allocated to a ketogenic diet 73 Received dietary treatment 64 Did not receive treatment 9: changed mind 5 seizures improved 2 diagnosis changed 2 Allocation Allocated to control period before diet start 72 Received control period intervention 64 Did not receive intervention, 8 changed mind, 5 died 1 seizures improved, 1 diagnosis changed 1 Lost to follow-up 0 Discontinued intervention 9 Follow-Up Lost to follow-up 0 Discontinued intervention 0 Analyzed 54 Excluded from analysis as inadequate data 1 Analysis Analyzed 49 Excluded from analysis as inadequate data 15
17 Does it work? 160 % baseline seizures Controls Ketogenic diet ** 50% reduction in seizures 28/73 (38%) diet vs 4/72 (6%) controls (p<0.001) >90% reduction in seizures 5/72 (7%) diet vs no controls (p<0.03) 0 **Diet vs control p<0.001 Neal et al 2008
18 Comparative randomised controlled trials with newer AEDs in refractory epilepsy % >50% reduction in seizures 70% 60% 50% 40% 30% 20% 10% 0% Agent Topiramate Lamotrigine Ketogenic diet Control/placebo Biton et al 1999, Motte et al 1997, Neal et al 2008
19 Ketogenic diet Efficacy according to syndrome Mean % baseline seizures Symptomatic Generalised (N=44) Symptomatic Focal (N=41) Lennox Gastaut (N=11) Infantile Spasms (N=6) Myoclonic Astatic Epilepsy (N=4) SMEI (N=5) Neal et al 2008
20 Tolerability Reported at 3m (N=55) Withdrawals (N=10) Vomiting 13(23.6%) 1 Diarrhoea 7 (12.7%) 1 Abdominal pain 5 (9.1%) Constipation 18 (32.7%) 1 Medication 13 (23.6%) Lack of energy 13 (23.6%) Hunger 12 (21.8%) Increased seizures 1 Parental unhappiness 3 Behavioural food refusal 2 Extreme drowsiness 1
21 Randomised (n=145) Allocated to a classical diet 73 Received dietary treatment 61 Allocation Allocated to MCT diet 72 Received MCT intervention 64 Lost to follow-up 0 Discontinued intervention 10 Follow-Up Lost to follow-up 0 Discontinued intervention 15 Analysis 3m 45 Analysis 6m 30 Analysis 12m 22 Analysis Analysis 3m 49 Analysis 6m 34 Analysis 12m 25
22 Should a specific diet be used? 90 Responder rates MCT Classical Percentage of baseline seizures (mean and 95% CI) m N=72 N=73 >50% reduction 21 (29.2%) 18 (24.7%) >90% reduction 2(2.7%) 5(6.8%) 6m >50% reduction 14 (19.4%) 18(23.7%) >90% reduction 4(5.6%) 6(8.2%) 12m >50% reduction 16(22.2%) 13(17.8%) Classical diet Diet group MCT diet >90% reduction 7(9.7%) 7(9.6%) P>0.1 Neal et al 2008
23 Tolerability at 3 months Classical MCT p N=47 N=42 Vomiting 28% 26% >0.05 Diarrhoea 15% 14% >0.05 Abdominal pain 11% 19% >0.05 Constipation Treatment 45% 31% 33% 26% >0.05 >0.05 Hunger 26% 33% >0.05 Taste problems 21% 17% >0.05 Lack of energy 17/47 (36%) 6/42 (14%) <0.05 Neal et al 2008
24 Tolerability at 12 months Classical N=20 MCT N=23 p Vomiting 45% 13% <0.05 * Diarrhoea 10% 17% >0.05 Abdominal pain 10% 17% >0.05 Constipation Treatment 45% 31% 39% 26% >0.05 >0.05 Hunger 25% 17% >0.05 Taste problems 15% 22% >0.05 Lack of energy 10% 13% >0.05 Neal et al 2008
25 Additional benefits at 3 months Classical MCT Increased alertness Increased awareness Increased responsiveness 83% 76% 83% 71% 83% 74%
26 Withdrawals before 3 months Classical (10/61) MCT (15/64) Increased seizures 4 1 Parental unhappiness 2 4 Diarrhoea 0 3 Constipation 1 0 Extreme drowsiness Textural food problems Behavioural food refusal 3 4 Vomiting 0 1 Lamotrigine 4% Topiramate 10% Neal et al 2008
27 Growth Classical diet MCT diet Mean paired difference P value Mean paired difference P value Weight Height Baseline 3mo Baseline 6 mo Baseline 12 mo Baseline 3mo Baseline 6 mo (n=37) (n=29) (n=19) (n=31) (n=20) (n=38) (n=30) (n=21) (n= (n=22) Baseline 12 mo (n=18) (n=15) Neal et al 2008
28 Growth - trends over 12 months Slopes of the best-fit regression lines of serial weight and height Z-score measures were used as values to represent growth trend during the year in 40 children who completed 12 months of treatment. There were no significant differences in mean slope between the classical (n=19) and MCT (n=21) diet groups for either weight (p=0.611) or height (p=0.912). Neal et al 2008
29 Growth mean energy and protein intakes over 12 months Diet Mean intake over 12 months Energy (kcal/kg) Protein (g/kg) MCT (n=21) Classical (n=19) P value Neal et al 2008
30 Conclusions Ketogenic diet is effective in the treatment of drug resistant epilepsy & is well tolerated Results of RCT (Class I evidence) suggest efficacy comparable to any new AED No evidence of benefit one diet over another No evidence of efficacy in one syndrome over another Children should be monitored throughout
31 Acknowledgements Hospital Services Association Charitable Trust Milk Development Council THE HENRY SMITH CHARITY All the patients & parents who participated in the trial as well as paediatricians who referred them
32
Ketogenic Diet Neurology & Beyond J Helen Cross UCL-Great Ormond Street Institute of Child Health, London & Young Epilepsy, Lingfield
Ketogenic Diet Neurology & Beyond J Helen Cross UCL-Great Ormond Street Institute of Child Health, London & Young Epilepsy, Lingfield The ketogenic diet What is it? A high fat diet, designed to mimic the
More informationWorkshop Ketogenic diets. Christin Eltze Consultant Paediatric Neurologist Great Ormond Street Hospital for Children NHS Trust
Workshop Ketogenic diets Christin Eltze Consultant Paediatric Neurologist Great Ormond Street Hospital for Children NHS Trust History Fasting suppresses seizure activity: Conklin (J Am Osteopatic Assoc
More informationEpilepsy management What, when and how?
Epilepsy management What, when and how? J Helen Cross UCL-Institute of Child Health, Great Ormond Street Hospital for Children, London, & National Centre for Young People with Epilepsy, Lingfield, UK What
More informationGhee Whiz! The Growing Evidence for the Benefits of the Modified Atkins Diet
Current Literature In Clinical Science Ghee Whiz! The Growing Evidence for the Benefits of the Modified Atkins Diet Use of the Modified Atkins Diet for Treatment of Refractory Childhood Epilepsy: A Randomized
More informationLRI Children s Hospital
LRI Children s Hospital Management of Children on Ketogenic Diet for Epilepsy Staff relevant to: Health professionals caring for children with epilepsy being managed on a ketogenic diet. Team approval
More informationDietary Approaches to Non-Lesional Epilepsy December 8, 2013
Dietary Approaches to Non-Lesional Epilepsy December 8, 2013 Eric H. Kossoff, MD Johns Hopkins University Baltimore, Maryland American Epilepsy Society Annual Meeting 1 Disclosures Nutricia, Inc. Atkins
More informationEpilepsy in the Primary School Aged Child
Epilepsy in Primary School Aged Child Deepak Gill Department of Neurology and Neurosurgery The Children s Hospital at Westmead CHERI Research Forum 15 July 2005 Overview The School Age Child and Epilepsy
More informationICD-9 to ICD-10 Conversion of Epilepsy
ICD-9-CM 345.00 Generalized nonconvulsive epilepsy, without mention of ICD-10-CM G40.A01 Absence epileptic syndrome, not intractable, with status G40.A09 Absence epileptic syndrome, not intractable, without
More informationThe Ketogenic Diet: Adolescents Can Do It, Too
Epilepsia, 44(6):847 851, 2003 Blackwell Publishing, Inc. C 2003 International League Against Epilepsy The Ketogenic Diet: Adolescents Can Do It, Too Mackenzie A. Mady, Eric H. Kossoff, Amy L. McGregor,
More informationKetogenic Diet Treatment - Malaysian Experience. Dr. Teik Beng Khoo Paediatric Institute Hospital Kuala Lumpur
Ketogenic Diet Treatment - Malaysian Experience Dr. Teik Beng Khoo Paediatric Institute Hospital Kuala Lumpur The Beginning Ketogenic diet (KD) treatment was first started among a small group of Malaysian
More informationUpdated advice for nurses who care for patients with epilepsy
NICE BULLETIN Updated advice for nurses who care for patients with epilepsy NICE provided the content for this booklet which is independent of any company or product advertised NICE BULLETIN Updated advice
More informationPediatric Epilepsy Care in Milwaukee
Pediatric Epilepsy Care in Milwaukee Priya Monrad, MD Assistant Professor, Pediatric Neurology and Epilepsy Children s Hospital of Wisconsin Disclosures I have no relevant financial relationships to disclose.
More informationKetogenic diet and other dietary therapies in epilepsy. Randa Jarrar, MD
Ketogenic diet and other dietary therapies in epilepsy Randa Jarrar, MD Ketogenic diet: History What is involved Efficacy Complications How does it work Variations: MCT ketogenic diet Low glycemic index
More information27/08/58. Kwan, P. and M.J. Brodie, Early identification of refractory epilepsy. N Engl J Med, (5): p
Pharmocologic Rx Other treatments: KD& VNS 1 st drug response - 47% 2 nd & 3 rd drug response - 14% Polytherapy response - 3% Dr Krisnachai Chomtho MD DCH MRCPCH Lecturer in pediatric neurology King Chulalongkorn
More informationAPPENDIX S. Removed sections from original guideline. 1.1 Pharmacological treatment Introduction
00 0 APPENDIX S Removed sections from original guideline. Pharmacological treatment.. Introduction The evidence base for the newer AEDs (gabapentin, lamotrigine, levetiracetam, oxcarbazepine, tiagabine,
More informationKetogenic diet for epilepsy
Ketogenic diet for epilepsy Published Jun 24, 1998 Version 1 Findings by SBU Alert The ketogenic diet has been used for intractable epilepsy in children, and is a method that has been used sporadically
More informationKetogenic diet in patients with myoclonic-astatic epilepsy
Original article Epileptic Disord 2006; 8 (2): 151-5 Ketogenic diet in patients with myoclonic-astatic epilepsy Roberto Horacio Caraballo 1, Ricardo Oscar Cersósimo 1, Diego Sakr 1, Araceli Cresta 2, Nidia
More informationPaediatric Epilepsy Update N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y
Paediatric Epilepsy Update 2018 N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y Epilepsy Service CUH ~550 children New diagnosis-education, support, clinic follow up Epilepsy
More informationNo relevant disclosures
No relevant disclosures - Epileptic Encephalopathy (EE): Epileptic activity itself contributes to cognitive and behavioural impairments - Developmental and Epileptic Encephalopathy (DEE): Impairments occur
More informationUse of the Modified Atkins Diet in Intractable Pediatric Epilepsy
Original Article Journal of Epilepsy Research pissn 2233-6249 / eissn 2233-6257 Use of the Modified Atkins Diet in Intractable Pediatric Epilepsy Eu Gene Park, MD, Jiwon Lee, MD, Jeehun Lee, MD, PhD Department
More informationepilepsy The Medium Chain Triglyceride diet and intractable
Archives of Diseases in Childhood, 1986, 61, 1168-1172 The Medium Chain Triglyceride diet and intractable epilepsy M A SILLS, W I FORSYTHE, D HAIDUKEWYCH, A MACDONALD, AND M ROBINSON General Infirmary
More informationKarin Borges, PhD. October The urgent need for new metabolic (dietary) treatments of epilepsy
Karin Borges, PhD October 2016 The urgent need for new metabolic (dietary) treatments of epilepsy Epilepsy is a common neurological disease that is characterized by recurrent seizures due to the spontaneous
More informationThe ketogenic diet for children with epilepsy
The ketogenic diet for children with epilepsy This leaflet has been given to you to help answer some of the questions you may have about the ketogenic diet as a treatment for epilepsy in children. If you
More informationReview Article The Modified Atkins Diet in Refractory Epilepsy
Hindawi Publishing Corporation Epilepsy Research and Treatment Volume 2014, Article ID 404202, 6 pages http://dx.doi.org/10.1155/2014/404202 Review Article The Modified Atkins Diet in Refractory Epilepsy
More informationSeizure Management Quality Care for Our Patients
Seizure Management Quality Care for Our Patients Case 6 Jack Pellock, MD 8 year old female with refractory epilepsy Multiple handicaps, developmental delay Cerebral palsy spastic diplegia but ambulatory
More informationRevisiting the Ketogenic Diet and Related Therapies in the Modern Era
Revisiting the Ketogenic Diet and Related Therapies in the Modern Era Heung Dong Kim M.D., Ph.D. Pediatric Epilepsy Clinic, Division of Pediatric Neurology Severance Children s Hospital Yonsei University
More informationSuccessful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report
*Manuscript Click here to view linked References Successful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report Thompson AGB 1, Cock HR 1,2. 1 St George s University
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE. Final Appraisal Determination. Newer drugs for epilepsy in children
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guidance 1.1 The newer antiepileptic drugs gabapentin, lamotrigine, oxcarbazepine, tiagabine, topiramate, and vigabatrin (as an adjunctive therapy for partial
More informationDietary Therapy For GLUT1 What are parents telling the experts?
Dietary Therapy For GLUT1 What are parents telling the experts? Eric H. Kossoff, MD Professor, Neurology and Pediatrics Medical Director, Ketogenic Diet Program Johns Hopkins Hospital Baltimore, Maryland
More informationApproaches to Treatment of Epilepsy Syndromes Elizabeth A. Thiele, MD, PhD
Approaches to Treatment of Epilepsy Syndromes Elizabeth A. Thiele, MD, PhD Director, Pediatric Epilepsy Program Massachusetts General Hospital Professor of Neurology Harvard Medical School Approaches to
More informationThe epilepsies: pharmacological treatment by epilepsy syndrome
The epilepsies: pharmacological treatment by epilepsy syndrome This table provides a summary reference guide to pharmacological treatment. Anti-epileptic drug (AED) options by epilepsy syndrome Childhood
More informationp ผศ.นพ.ร งสรรค ช ยเสว ก ล คณะแพทยศาสตร ศ ร ราชพยาบาล
Natural Course and Prognosis of Epilepsy p ผศ.นพ.ร งสรรค ช ยเสว ก ล คณะแพทยศาสตร ศ ร ราชพยาบาล Introduction Prognosis of epilepsy generally means probability of being seizure-free after starting treatment
More informationCurrent views on epilepsy management
Current views on epilepsy management J Helen Cross UCL-Institute of Child Health, Great Ormond Street Hospital for Children NHS Foundation Trust, London & Young Epilepsy, Lingfield, UK What are our current
More informationChildhood Epilepsy - Overview & Update
Childhood Epilepsy - Overview & Update Nicholas Allen Dept. Paediatrics Mar 2016 NO DISCLOSURES Videos 1 Outline: Childhood Epilepsy What is it? How do we classify it? How do we diagnose it? How do we
More informationEffectiveness of Medium Chain Triglyceride Ketogenic Diet in Thai Children with Intractable Epilepsy
Effectiveness of Medium Chain Triglyceride Ketogenic Diet in Thai Children with Intractable Epilepsy Krisnachai Chomtho MD*, Orapa Suteerojntrakool MD*, Sirinuch Chomtho MD* * Department of Pediatrics,
More informationLevetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study
Seizure (2006) 15, 214 218 www.elsevier.com/locate/yseiz CASE REPORT Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study Angelo Labate a,b, Eleonora Colosimo
More informationChildhood Epilepsy Syndromes. Epileptic Encephalopathies. Today s Discussion. Catastrophic Epilepsies of Childhood
CATASTROPHIC EPILEPSIES OF CHILDHOOD EPILEPTIC ENCEPHALOPATHIES Dean Sarco, MD Department of Neurology Kaiser Permanente Los Angeles Medical Center Childhood Epilepsy Syndromes Epilepsy Syndrome Grouping
More informationQ9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
updated 2012 When to discontinue antiepileptic drug treatment in adults and children Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued? Background
More informationReview Article A Systematic Review of the Use of the Ketogenic Diet in Childhood Epilepsy. Daniel L. Keene, MD, MA
Review Article A Systematic Review of the Use of the Ketogenic Diet in Childhood Epilepsy Daniel L. Keene, MD, MA The ketogenic diet has been used in the treatment of intractable childhood epilepsy since
More informationfor a bright reaching resources
resources e Glut1 Deficiency Foundation is a non-profit family organization dedicated to improving the lives of those in the Glut1 Deficiency community through its mission of: increased awareness improved
More informationBIBLIOGRAPHIC REFERENCE TABLE FOR SODIUM VALPROATE IN CHILDHOOD EPILEPSY
BIBLIOGRAPHIC REFERENCE TABLE FOR SODIUM VALPROATE IN CHILDHOOD EPILEPSY Bibliographic Marson AG et al. for (Review). The Cochrane 2000 De Silva M et al. Romised or for childhood. Lancet, 1996; 347: 709-713
More informationNewer drugs for epilepsy in children
NHS National Institute for Clinical Excellence Newer drugs for epilepsy in children Technology Appraisal 79 April 2004 Technology Appraisal Guidance 79 Newer drugs for epilepsy in children Issue date:
More informationClassification of Seizures. Generalized Epilepsies. Classification of Seizures. Classification of Seizures. Bassel F. Shneker
Classification of Seizures Generalized Epilepsies Bassel F. Shneker Traditionally divided into grand mal and petit mal seizures ILAE classification of epileptic seizures in 1981 based on clinical observation
More informationMarleen Van Driessche Dietitian University Hospital Ghent, Belgium. The Ketogenic Diet
Marleen Van Driessche Dietitian University Hospital Ghent, Belgium The Ketogenic Diet The Ketogenic Diet, what is it? What is it? High En% of fat 70 90 En% Adequate protein intake 6 7 En% Low En% of carbohydrates
More informationKetogenic Diet therapy in Myoclonic-Atonic Epilepsy (MAE)
KD therapy in epilepsy syndromes Ketogenic Diet therapy in Myoclonic-Atonic Epilepsy (MAE) Hirokazu Oguni, MD Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan Epilepsy Center, TMG
More informationScottish Medicines Consortium
Scottish Medicines Consortium levetiracetam, 250, 500, 750 and 1000mg tablets and levetiracetam oral solution 100mg/ml (Keppra ) No. (394/07) UCB Pharma Limited 10 August 2007 The Scottish Medicines Consortium
More informationRESEARCH ARTICLE A MODIFIED ATKINS DIET FOR INTRACTABLE CHILDHOOD EPILEPSY
RESEARCH ARTICLE A MODIFIED ATKINS DIET FOR INTRACTABLE CHILDHOOD EPILEPSY Mohammad BARZEGAR MD 1, Poupak IRANDOUST BSc 2, Mehrangiz EBRAHIMI MAMEGHANI PhD 3 1.Professor of Pediatric Neurology, Pediatric
More informationEpilepsies of Childhood: An Over-view of Treatment 2 nd October 2018
Epilepsies of Childhood: An Over-view of Treatment 2 nd October 2018 Dr Sophia Varadkar MRCPI, PhD Consultant Paediatric Neurologist and Honorary Senior Lecturer Great Ormond Street Hospital for Children
More informationSupporting your child s success on the ketogenic diet
Eva, KetoCal user Supporting your child s success on the ketogenic diet KetoCal is a medical food for use under supervision A caregiver s guide to the ketogenic diet and the support & resources available
More informationSaving the Day - the Medical Mission
Saving the Day - the Medical Mission Dr Sukhvir Wright Honorary Consultant Neurologist, Birmingham Children s Hospital Research Fellow, Aston University My mission today Introduction Epilepsy Epilepsy
More informationChronic Management of Idiopathic Generalized epilepsies (IGE) Hassan S.Hosny M.D. Prof of Neurology, Cairo University
Chronic Management of Idiopathic Generalized epilepsies (IGE) Hassan S.Hosny M.D. Prof of Neurology, Cairo University Sanaa 2009 Points of Discussion Prevalence compared to focal epilepsy Adult form Status
More information01/11/2012. Neurological disorders and nutrition. Nutritional and related assessments. Non-nutritional causes: nutritional implications
Neurological disorders and nutrition General considerations, e.g., dysphagia Main topics and optional Canadian websites: STROKES www.heartandstroke.ca EPILEPSY www.epilepsy.ca PARKINSON S www.parkinson.ca
More informationOpinion 24 July 2013
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 24 July 2013 FYCOMPA 2 mg, film-coated tablet B/7 (CIP: 34009 267 760 0 8) B/28 (CIP: 34009 268 447 4 5) FYCOMPA 4
More informationEEG in the Evaluation of Epilepsy. Douglas R. Nordli, Jr., MD
EEG in the Evaluation of Epilepsy Douglas R. Nordli, Jr., MD Contents Epidemiology First seizure Positive predictive value Risk of recurrence Identifying epilepsy Type of epilepsy (background and IEDs)
More informationSeizure remission in adults with long-standing intractable epilepsy: An extended follow-up
Epilepsy Research (2010) xxx, xxx xxx journal homepage: www.elsevier.com/locate/epilepsyres Seizure remission in adults with long-standing intractable epilepsy: An extended follow-up Hyunmi Choi a,, Gary
More informationlevetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd
Scottish Medicines Consortium Resubmission levetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd 11 January 2008 The Scottish Medicines
More informationLMMG New Medicine Recommendation
LMMG New Medicine Recommendation Oxcarbazepine (Trileptal ) for the treatment of epilepsy LMMG Recommendation: Amber 0: Oxcarbazepine (Trileptal ) is recommended for use as monotherapy or adjunctive therapy
More informationThe Outcome of Children with Intractable Seizures: A 3- to 6-Year Follow-up of 67 Children Who Remained on the Ketogenic Diet Less Than One Year
Epilepsia, 47(2):425 430, 2006 Blackwell Publishing, Inc. C 2006 International League Against Epilepsy The Outcome of Children with Intractable Seizures: A 3- to 6-Year Follow-up of 67 Children Who Remained
More informationRetrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients
Acta neurol. belg., 2000, 100, 171-176 Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients J. THIJS, H. VERHELST,
More informationOn completion of this chapter you should be able to: list the most common types of childhood epilepsies and their symptoms
9 Epilepsy The incidence of epilepsy is highest in the first two decades of life. It falls after that only to rise again in late life. Epilepsy is one of the most common chronic neurological condition
More informationNew Medicines Profile
New Medicines Profile February 2010 Issue No. 10/02 Eslicarbazepine Concise evaluated information to support the managed entry of new medicines in the NHS Brand Name, (Manufacturer): Zebinix (Eisai Limited)
More informationStaging of Seizures According to Current Classification Systems December 10, 2013
Staging of Seizures According to Current Classification Systems December 10, 2013 Elinor Ben-Menachem, M.D.,Ph.D, Instituet of Clinical Neuroscience and Physiology, Sahlgren Academy, Goteborg University,
More informationIdiopathic Epileptic Syndromes
Idiopathic Epileptic Syndromes Greek words idios = self, own and personal pathic = suffer Kamornwan Katanuwong MD Chiangmai University Hospital 1 st Epilepsy Camp, Hua Hin 20 th August 2010 Is a syndrome
More informationAPPENDIX K Pharmacological Management
1 2 3 4 APPENDIX K Pharmacological Management Table 1 AED options by seizure type Table 1 AED options by seizure type Seizure type First-line AEDs Adjunctive AEDs Generalised tonic clonic Lamotrigine Oxcarbazepine
More informationEfficacy and safety of levetiracetam in infants and young children with refractory epilepsy
Seizure (2007) 16, 345 350 www.elsevier.com/locate/yseiz Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy S. Grosso a, D.M. Cordelli a, E. Franzoni b, G. Coppola
More informationThe epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care Issued: January 2012 guidance.nice.org.uk/cg137 NHS Evidence has accredited the process
More informationThe epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care Issued: January 2012 last modified: January 2015 guidance.nice.org.uk/cg137 NICE has
More informationPharmacological Treatment of Non-Lesional Epilepsy December 8, 2013
Pharmacological Treatment of Non-Lesional Epilepsy December 8, 2013 Michael Privitera, MD Professor of Neurology University of Cincinnati, Neuroscience Institute American Epilepsy Society Annual Meeting
More informationeslicarbazepine acetate 800mg tablet (Zebinix) SMC No. (592/09) Eisai Ltd
eslicarbazepine acetate 800mg tablet (Zebinix) SMC No. (592/09) Eisai Ltd 8 October 2010 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards
More informationEf cacy of the Atkins Diet as Therapy for Intractable Epilepsy in Children
Atkins Diet in Childhood Intractable Epilepsy Original Article Ef cacy of the Atkins Diet as Therapy for Intractable Epilepsy in Children Seyed Hassan Tonekaboni MD 1,2, Parvin Mostaghimi 3, Parvin Mirmiran
More informationWhat do we know about prognosis and natural course of epilepsies?
What do we know about prognosis and natural course of epilepsies? Dr. Chusak Limotai, MD., M.Sc., CSCN (C) Chulalongkorn Comprehensive Epilepsy Center of Excellence (CCEC) The Thai Red Cross Society First
More informationClinical Aspects of the Ketogenic Diet
Epilepsia, 48(1):31 42, 2007 Blackwell Publishing, Inc. C 2007 International League Against Epilepsy Critical Reviews Clinical Aspects of the Ketogenic Diet Adam L. Hartman and Eileen P. G. Vining The
More informationRefractory epilepsy: treatment with new antiepileptic drugs
Seizure 2000; 9: 51 57 doi: 10.1053/seiz.1999.0348, available online at http://www.idealibrary.com on Refractory epilepsy: treatment with new antiepileptic drugs P. K. DATTA & P. M. CRAWFORD Department
More informationDietary Therapy What are the parents actually doing?
Dietary Therapy What are the parents actually doing? Eric H. Kossoff, MD Professor, Neurology and Pediatrics Medical Director, Ketogenic Diet Program Johns Hopkins Hospital Baltimore, Maryland USA The
More informationMCADD. MEDIUM CHAIN ACYL CoA DEHYDROGENASE DEFICIENCY. Dietary management guidelines for dietitians
MCADD MEDIUM CHAIN ACYL CoA DEHYDROGENASE DEFICIENCY Dietary management guidelines for dietitians AUTHOR Marjorie Dixon Principal Paediatric Dietitian, Great Ormond Street Hospital for Children, NHS Trust,
More informationChapter 16: Ketogenic Diets
Chapter 16: Ketogenic Diets 1. Wilder RM The effects of ketonuria on the course of epilepsy. Mayo Clin Bull, 1921, 2 307. 2. National Institute for Health and Clinical Excellence Clinical Guideline 20:
More informationA Guide to Your Visits for the FAiRE LGS Study
A Guide to Your Visits for the FAiRE LGS Study ( Fenfluramine Assessment in Rare Epilepsy) Thank you for enrolling in the FAiRE-LGS research study. This study will assess whether an investigational drug
More informationmg 25 mg mg 25 mg mg 100 mg 1
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationDiagnosis and management of the epilepsies in children
PRESCRIBING IN CHILDREN Diagnosis and management of the epilepsies in children CHRISTINE PRAGER AND J HELEN CROSS There are many different types of epilepsy that can occur in childhood, therefore identification
More informationEpilepsy and EEG in Clinical Practice
Mayo School of Professional Development Epilepsy and EEG in Clinical Practice November 10-12, 2016 Hard Rock Hotel at Universal Orlando Orlando, FL Course Directors Jeffrey Britton, MD and William Tatum,
More informationEarly-onset eating disorders
Early-onset eating disorders Principal investigators Debra K. Katzman, MD, FRCPC, Division of Adolescent Medicine, Department of Paediatrics* Anne Morris, MB, BS, MPH, FRACP, Division of Adolescent Medicine,
More informationShared Care Guidance. Vigabatrin
North of Tyne Area Prescribing Committee Shared Care Guidance Vigabatrin July 2014 (Review date July 2016) This guidance has been prepared and approved for use in Newcastle, North Tyneside and Northumberland.
More informationTherapeutic strategies in the choice of antiepileptic drugs
Acta neurol. belg., 2002, 102, 6-10 Original articles Therapeutic strategies in the choice of antiepileptic drugs V. DE BORCHGRAVE, V. DELVAUX, M. DE TOURCHANINOFF, J.M. DUBRU, S. GHARIANI, Th. GRISAR,
More informationTopiramate in clinical practice: first year s postlicensing experience in a specialist epilepsy clinic
J Neurol Neurosurg Psychiatry 1999;66:759 763 759 The Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool L9 7LJ, UK M W Kellett D F Smith P A Stockton D W Chadwick Correspondence to: Dr
More information2018 American Academy of Neurology
Practice Guideline Update Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-Resistant Epilepsy Report by: Guideline Development, Dissemination, and Implementation Subcommittee of the
More informationModified Atkins diet is an effective treatment for children with Doose syndrome
FULL-LENGTH ORIGINAL RESEARCH Modified Atkins diet is an effective treatment for children with Doose syndrome *Adelheid Wiemer-Kruel, Edda Haberlandt, Hans Hartmann, Gabriele Wohlrab, and *Thomas Bast
More informationDifficult to treat childhood epilepsy: Lessons from clinical case scenario
Difficult to treat childhood epilepsy: Lessons from clinical case scenario Surachai Likasitwattanakul, M.D. Department of Pediatrics Faculty of Medicine, Siriraj Hospital Natural history of Epilepsy Untreated
More informationEEG in Epileptic Syndrome
EEG in Epileptic Syndrome Surachai Likasitwattanakul, M.D. Division of Neurology, Department of Pediatrics Faculty of Medicine, Siriraj Hospital Mahidol University Epileptic syndrome Electroclinical syndrome
More informationLow Carbohydrate Diets and The Brain
Low Carbohydrate Diets and The Brain Eric H. Kossoff, MD Medical Director, Ketogenic Diet Center Associate Professor, Neurology and Pediatrics Johns Hopkins Hospital Baltimore, Maryland July 9, 2010 Topics
More informationAN INTRODUCTION TO. Medical Ketogenic Dietary Therapies
AN INTRODUCTION TO Medical Ketogenic Dietary Therapies The Matthew s Friends Organisation The Background: Matthew Williams suffers with a catastrophic form of epilepsy called Dravet Syndrome and his seizures
More informationNeuromuscular Disease(2) Epilepsy. Department of Pediatrics Soochow University Affiliated Children s Hospital
Neuromuscular Disease(2) Epilepsy Department of Pediatrics Soochow University Affiliated Children s Hospital Seizures (p130) Main contents: 1) Emphasize the clinical features of epileptic seizure and epilepsy.
More informationModified Atkins diet in adult with refractory epilepsy: A controlled randomized clinical trial
Iranian Journal of Neurology Original Paper Iran J Neurol 2017; 16(2): 72-7 Modified Atkins diet in adult with refractory epilepsy: A controlled randomized clinical trial Received: 17 Dec. 2016 Accepted:
More informationPage: 1 / 5 Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York
Weight management using a meal replacement strategy: meta and pooling analysis from six studies Heymsfield S B, van Mierlo C A, van der Knaap H C, Heo M, Frier H I CRD summary The review assessed partial
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 05 May 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 05 May 2010 LAMICTAL 2 mg, dispersible / chewable tablet B/30 (CIP: 354 581-7) LAMICTAL 5 mg, dispersible / chewable
More informationNew Drug Evaluation: brivaracetam [tablet and solution, oral; solution, intravenous]
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationnothing is perfect Problems with triheptanoin and clinical trials
nothing is perfect Problems with triheptanoin and clinical trials MILAN, Italy, 7th 8th ctober 2016 Joerg Klepper The State-and-Region Agreement asks for a declaration by Moderators, Speakers, Teachers
More information- biochemical principles - practical applications
The ketogenic diet in pediatric neurology practice - biochemical principles - practical applications Some points from history 1921-1928: «The efficiency of fasting» and being free of seizures 1921-1970:
More informationSUDEP: Minimizing Risk
SUDEP: Minimizing Risk ELIZABETH J. DONNER, MD, MSC, FRCPC THE HOSPITAL FOR SICK CHILDREN UNIVERSITY OF TORONTO Learning Objectives 1. Evaluate SUDEP risk 2. Consider strategies SUDEP prevention 3. Discuss
More informationEvaluation and management of drug-resistant epilepsy
Evaluation and management of drug-resistant epilepsy Fateme Jahanshahifar Supervised by: Professor Najafi INTRODUCTION 20 to 40 % of patients with epilepsy are likely to have refractory epilepsy. a substantive
More informationKETOGENIC DIET ISMAIL HALAHLEH, MSC. نقیب اخصاي یي التغذیة الفلسطینیین
KETOGENIC DIET ISMAIL HALAHLEH, MSC. نقیب اخصاي یي التغذیة الفلسطینیین INTRODUCTION WHAT IS KETOGENIC DIET???? KETOGENIC DIET The ketogenic diet (KD) is a diet that is high in fat, low in carbohydrate,
More information